Description
About Migrabeta-TR 20 Tablet
Migrabeta-TR 20 Tablet is used alone or together with other medicines to treat high blood pressure (hypertension), heart-related chest pain (angina), heart rhythm disorder (arrhythmia) and preventing symptoms of migraine headache and tremors (fits). It affects our heart and blood circulatory system, especially controlling blood through arteries and veins. High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart and kidneys, resulting in a stroke, heart failure, or kidney failure. Lowering blood pressure may reduce the risk of stroke and heart attacks.
Migrabeta-TR 20 Tablet plays a vital role in relaxing our blood vessels by blocking the action of certain natural substances in your body. This lowers your blood pressure and helps reduce your risk of a stroke, a heart attack, other heart problems or kidney problems in the future. This medicine needs to be taken regularly to be effective.
You can take Migrabeta-TR 20 Tablet orally with or without food or as directed by your physician. Swallow the whole tablet with a glass of water. Do not crush, chew or break it. Migrabeta-TR 20 Tablet is preferable to take at the same time every day for better results. Migrabeta-TR 20 Tablet is generally safe to consume. You may have common side effects like feeling dizzy or exhausted, cold hands or feet, difficulty sleeping, and nightmares. These side effects are usually mild and short-lived. However, if the side effects are persistent, reach out to your doctor.
Don’t stop taking Migrabeta-TR 20 Tablet without talking to your doctor first. Stopping Migrabeta-TR 20 Tablet gradually may cause heart rhythm and blood pressure changes and cause chest pain or a heart attack. Your doctor will lower your dose gradually over some time to help prevent these symptoms. You should not use Migrabeta-TR 20 Tablet if you have a very slow heartbeat, asthma, serious heart condition (sick sinus syndrome) or any heart blockage. Children weighing less than 4.5 pounds should not be given a Migrabeta-TR 20 Tablet . It should not be given to children less than 12 years of age. Before taking Migrabeta-TR 20 Tablet , you should tell the doctor if you have any muscle disorder (myasthenia gravis, rhabdomyolysis), breathing problems (COPD, bronchitis, emphysema), low blood sugar level (hypoglycaemia), low blood pressure (hypotension), depression, previous heart failure, liver/kidney disease, thyroid hormone disorder, adrenal gland cancer or problems with circulation (Raynaud’s syndrome).
Uses of Migrabeta-TR 20 Tablet
Medicinal Benefits
Migrabeta-TR 20 Tablet works by blocking both beta receptors, namely beta 1 and beta 2. Migrabeta-TR 20 Tablet blocks the beta 1 receptor located in the heart’s cells, lowering heart rate and decreasing heart blood pumping frequency, decreasing raised blood pressure. On the other hand, Migrabeta-TR 20 Tablet also blocks beta 2 receptors located in the lungs (bronchioles) and blood vessels of skeletal muscle, narrowing it. This, in turn, lowers your overall body’s blood pressure and helps reduce the risk of a stroke, a heart attack, heart problems or kidney problems in the future. Migrabeta-TR 20 Tablet also improves the symptoms of heart-related chest pain (angina) and may increase a person’s stamina to do exercise with angina. Migrabeta-TR 20 Tablet is used in combination with thiazide diuretics and other medicines to treat high blood pressure. Additionally, Migrabeta-TR 20 Tablet reduces symptoms of essential tremor (fits) and prevents migraine. Migrabeta-TR 20 Tablet can reduce symptoms of too much thyroid hormone (thyrotoxicosis) and can be taken together with thyroid-related medicines to treat an overactive thyroid.
Directions for Use
Storage
Side Effects of Migrabeta-TR 20 Tablet
- Headaches
- Feeling tired, dizzy or weak
- Cold fingers or toes
- Feeling or being sick (nausea or vomiting)
- Diarrhoea
- Stomach pain
Reviews
There are no reviews yet.